With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD||Young Investigator Grants||2012||Washington|
|Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy||Dana-Farber Cancer Institute / Yana Pikman, MD||Young Investigator Grants||2014||Massachusetts|
|Treating Brain Tumor by Changing Cell Division Pattern||Yale School of Medicine / Weimin Zhong||Innovation Grants||2010||Connecticut|
|Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors||University of Florida / Chen Ling||Young Investigator Grants||2012||Florida|
|Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide||University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD||Young Investigator Grants||2008||Texas|
|Trib2 in the Pathogenesis of T-ALL||University of Pennsylvania / Warren Pear, M.D., Ph.D.,||Innovation Grants||2014||Pennsylvania|
|Trk-Targeted Therapy of Human Neuroblastomas||Children's Hospital of Philadelphia / Garrett Brodeur, M.D.||Bridge Grants||2014||Pennsylvania|
|TrkB Signaling in the Genesis of Murine Neuroblastoma||University of Vermont / Rae Nishi, PhD||Innovation Grants||2007||Vermont|
|Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma||The Pennsylvania State University / Ken Lucas, MD||Innovation Grants||2006||Pennsylvania|
|Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer||Baylor College of Medicine / Stephen Gottschalk, M.D.||Innovation Grants||2014||Texas|